Evidence map›Paper›PMID 32350310›Full record

ArticleScientific reports2020

The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling.

Emre Karakus, Marie Wannowius, Simon Franz Müller, Silke Leiting, Regina Leidolf, Saskia Noppes, Stefan Oswald, Martin Diener, Joachim Geyer

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. SLC10A7 regulates O-GalNAc glycosylation and CaCellular and molecular life sciences : CMLS · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  9. Store-operated CaPNAS nexus · 2023
    Article
  10. HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9.Frontiers in cell and developmental biology · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Emre KarakusInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.ORCID http://orcid.org/0000-0002-0822-0054
Marie WannowiusInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.
Simon Franz MüllerInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.
Silke LeitingInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.
Regina LeidolfInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.
Saskia NoppesInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.
Stefan OswaldInstitute of Pharmacology, University of Greifswald, 17487, Greifswald, Germany.
Martin DienerInstitute of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany.
Joachim GeyerInstitute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392, Giessen, Germany. Joachim.M.Geyer@vetmed.uni-giessen.de.ORCID http://orcid.org/0000-0003-2663-1858
Justus-Liebig-Universität Gießen · DEUniversität Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SLC10A7 represents an orphan member of the Solute Carrier Family SLC10. Recently, mutations in the human SLC10A7 gene were associated with skeletal dysplasia, amelogenesis imperfecta, and decreased bone mineral density. However, the exact molecular function of SLC10A7 and the mechanisms underlying these pathologies are still unknown. For this reason, the role of SLC10A7 on intracellular calcium signaling was investigated. SLC10A7 protein expression was negatively correlated with store-operated calcium entry (SOCE) via the plasma membrane. Whereas SLC10A7 knockout HAP1 cells showed significantly increased calcium influx after thapsigargin, ionomycin and ATP/carbachol treatment, SLC10A7 overexpression reduced this calcium influx. Intracellular Ca

Indexed as

Calcium SignalingAmino Acid SequenceCalciumCell LineHumansMutationNeoplasm ProteinsORAI1 ProteinOrganic Anion Transporters, Sodium-DependentRNA, MessengerSarcoplasmic Reticulum Calcium-Transporting ATPasesStromal Interaction Molecule 1SymportersATP2A2 protein, humanCalciumNeoplasm ProteinsORAI1 ProteinORAI1 protein, humanOrganic Anion Transporters, Sodium-DependentRNA, MessengerSarcoplasmic Reticulum Calcium-Transporting ATPasesSlc10a7 protein, humanSTIM1 protein, humanStromal Interaction Molecule 1Symporters

Identifiers

PMID32350310
PMCPMC7190670
OpenAlexW3023864139

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.